Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

SHE:002793 Revenue

Luoxin Pharmaceuticals Group Stock had revenue of 582.73M CNY in the quarter ending March 31, 2026, a decrease of -23.97%. This brings the company's revenue in the last twelve months to 2.37B, down -2.78% year-over-year. In the year 2025, Luoxin Pharmaceuticals Group Stock had annual revenue of 2.27B, down -14.12%.

• Revenue (ttm): 2.37B
• Revenue Growth: -2.78%
• P/S Ratio: 1.97
• Revenue / Employee: 801.30K
• Employees: 2,962
• Market Cap: 4.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.27B	-373.91M	-14.12%
Dec 31, 2024	2.65B	283.50M	11.99%
Dec 31, 2023	2.36B	-1.22B	-34.11%
Jan 1, 2023	3.59B	-2.89B	-44.62%
Jan 1, 2022	6.48B	381.70M	6.26%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 1, 2026

Data Sources Report a data error